News
Sementis’ quest for an Australian second-generation COVID-19 vaccine
October 2021 A South Australian start-up biotech company, Sementis Limited, has joined the global quest to develop a...
August 2021
Adelaide biotech company Sementis is aiming to raise $10m to accelerate work on its next-generation Covid-19 vaccine, which it hopes to have in production within 18 months.
Digital subscribers to The Australian can read more here.